Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Accounts Payables (2016 - 2025)

Aethlon Medical filings provide 15 years of Accounts Payables readings, the most recent being $534524.0 for Q1 2025.

  • On a quarterly basis, Accounts Payables fell 31.28% to $534524.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $534524.0, a 31.28% decrease, with the full-year FY2025 number at $534524.0, down 31.28% from a year prior.
  • Accounts Payables hit $534524.0 in Q1 2025 for Aethlon Medical, down from $610909.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.1 million in Q2 2024 to a low of $226791.0 in Q4 2022.
  • Median Accounts Payables over the past 5 years was $499962.0 (2022), compared with a mean of $539232.9.
  • Biggest five-year swings in Accounts Payables: surged 205.64% in 2023 and later plummeted 31.28% in 2025.
  • Aethlon Medical's Accounts Payables stood at $234118.0 in 2021, then fell by 3.13% to $226791.0 in 2022, then surged by 205.64% to $693154.0 in 2023, then decreased by 11.87% to $610909.0 in 2024, then dropped by 12.5% to $534524.0 in 2025.
  • The last three reported values for Accounts Payables were $534524.0 (Q1 2025), $610909.0 (Q4 2024), and $922888.0 (Q3 2024) per Business Quant data.